1 completed, 1 suspended. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Suspended 1 |
| Phase 3 | 1 | Completed 1 |
Follow Cipla Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV Pramipexole ER, Escitalopram - Major Depressive Disorder, Mild Neurocognitive Disorder | Phase 2 | Suspended | National Institute of Allergy and Infectious Diseases (NIAID) | 186 | 2026-05-17 | 2026-07-14 |
| Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis Prednisolone, Voriconazole - Allergic Bronchopulmonary Aspergillosis | Phase 2 / Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 50 | 2013-06-01 | 2017-12-12 |
Aspergillosis, Allergic Bronchopulmonary (1) · Depressive Disorder, Major (1) · Neurocognitive Disorders (1)
Escitalopram (1) · Prednisolone (1) · Voriconazole (1)
India (2) · Botswana (1) · Brazil (1) · Kenya (1) · Malawi (1) · Mexico (1) · Peru (1) · Philippines (1) · South Africa (1) · Thailand (1) · Uganda (1) · United States (1) · Vietnam (1) · Zimbabwe (1)
Scott Letendre, MD (1) · William R Short, MD (1)